Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields). Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and
. malignant pleural mesothelioma. Novocure has ongoing and completed clinical trials investigating TTFields in glioblastoma, brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.